Status:
RECRUITING
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors
Lead Sponsor:
Huashan Hospital
Conditions:
Positron-Emission Tomography
Neoplasms
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will investigate the safety and preliminary diagnostic efficacy of \[68Ga\]Ga-NOTA-T4 or \[18F\]AlF-RESCA-T4 in pancreatic cancer, breast cancer, head and neck cancer, lung cancers and othe...
Eligibility Criteria
Inclusion
- Be between 18 and 65 years of age and of either sex.
- Patients with colorectal cancer confirmed by puncture or surgical pathology.
- Written informed consent signed by the subject or legal guardian or caregiver.
- Willingness and ability to cooperate with all programs of this study.
Exclusion
- Severe hepatic or renal insufficiency;
- Targeted therapy before radiotherapy or PET/CT scan；
- Renal function: serum creatinine less than or equal to the upper limit of the normal range;Liver function: bilirubin, AST(SGOT)/ALT(SGPT) less than or equal to the upper limit of the normal range；
- History of serious surgery in the last month. Those who have participated in other clinical trials during the same period.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06203574
Start Date
December 1 2023
End Date
December 1 2024
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital
Shanghai, China